Rozlytrek 100mg, 200mg (Capsule) Entrectinib
Intended for healthcare professionals only
This material should not be used as a substitute for professional medical advice or to promote any medication. For more information, please consult your physician
Rozlytrek (Entrectinib) capsule is a kinase inhibitor indicated for the treatment of adult patients with ROS1-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
Full prescribing information is available on request.
If you have a scientific query related to one of Roche's products, please contact us at [email protected]
In case of any adverse events or safety queries, please contact [email protected]
M-PK-00002297
Solutions
Pharma Products
![[Product] Rozyltrek](https://assets.roche.com/f/169232/768x511/ec0afb1122/rozyltrek200.jpg/m/320x180/filters:format(webp):quality(90)/)